Left Arrow IconPreviousRight Arrow IconNextPlus IconExpandMinus IconCollapseMagnifying Glass IconSearch

WebView

YearNumberLinkReferenceTitleAuthors
Hide details for Published in 2018Published in 2018
227ClickHaematologica. 2017 Dec 7. pii: haematol.2017.175729. doi: 10.3324/haematol.2017.175729. [Epub ahead of print]Somatic STAT3 mutations in the Felty syndrome: an implication for a common pathogenesis with large granular lymphocyte leukemia.Savola P, Brück O, Olson T, Kelkka T, Kauppi MJ, Kovanen PE, Kytölä S, Sokka-Isler T, Loughran TP, Leirisalo-Repo M, Mustjoki S.
226ClickSemin Arthritis Rheum. 2018 Feb;47(4):492-500. doi: 10.1016/j.semarthrit.2017.08.003. Epub 2017 Aug 9.Equivalence in the Health Assessment Questionnaire (HAQ) across socio-demographic determinants: Analyses within QUEST-RA.Hifinger M, Norton S, Ramiro S, Putrik P, Sokka-Isler T, Boonen A.
Hide details for Published in 2017Published in 2017
225ClickLääketieteellinen Aikakauskirja Duodecim 2017;133(18):1691-8NivelreumaVappu Rantalaiho, Tuulikki Sokka, Seppo Meri
224ClickClin Rheumatol. 2017 Nov 7. doi: 10.1007/s10067-017-3870-8. [Epub ahead of print]A cross-sectional study of vitamin D levels in a large cohort of patients with rheumatic diseases.Nikiphorou E, Uksila J, Sokka T.
223ClickRheumatology (Oxford). 2017 Aug 1;56(8):1395-1400. doi: 10.1093/rheumatology/kex076.Intercentre variance in patient reported outcomes is lower than objective rheumatoid arthritis activity measures: a cross-sectional study.Khan NA, Spencer HJ, Nikiphorou E, Naranjo A, Alten R, Chirieac RM, Drosos AA, Géher P, Inanc N, Kerzberg E, Ancuta CM, Müller R, Ørnbjerg L, Sokka T.
222ClickClin Exp Rheumatol. 2017 May-Jun;35(3):477-483. Epub 2017 Jan 27.The spectrum of early rheumatoid arthritis practice across the globe: results from a multinational cross sectional survey.Nikiphorou E, Galloway J, van Riel P, Yazici Y, Haugeberg G, Ostor A, Gogus F, Kauppi M, Sokka T; QUEST-RA Group
221ClickAnn Rheum Dis. 2017 Dec;76(12):e49. doi: 10.1136/annrheumdis-2017-211505. Epub 2017 Apr 27. No abstract available.Alternative interpretation of data for recommendations on how to manage rheumatoid arthritis.Pirilä L, Sokka T, Kauppi MJ, Rantalaiho VM, Mervaala E, Puolakka K.
220ClickScand J Rheumatol. 2017 Nov;46(6):425-431. doi: 10.1080/03009742.2016.1266029. Epub 2017 Apr 3.Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.Rannio T, Asikainen J, Hannonen P, Yli-Kerttula T, Ekman P, Pirilä L, Kuusalo L, Mali M, Puurtinen-Vilkki M, Kortelainen S, Paltta J, Taimen K, Kauppi M, Laiho K, Nyrhinen S, Mäkinen H, Isomäki P, Uotila T, Aaltonen K, Kautiainen H, Sokka T.
219ClickSemin Arthritis Rheum. 2017 Jun;46(6):732-739. doi: 10.1016/j.semarthrit.2016.09.005. Epub 2016 Sep 16.Effectiveness and drug survival of TNF-inhibitors in the treatment of psoriatic arthritis: A prospective cohort studyAaltonen K, Heinonen A, Joensuu J, Parmanne P, Karjalainen A, Varjolahti-Lehtinen T, Uutela T, Puurtinen-Vilkki M, Arstila L, Blom M, Sokka T, Nordström D.
218ClickArthritis Rheumatol. 2017 Apr;69(4):866-867. doi: 10.1002/art.40022. Epub 2017 Mar 3. No abstract available.Limited value of the multi-biomarker disease activity assay compared to the Routine Assessment of Patient Index Data 3 (RAPID3) score in the prognosis of important clinical outcomes in rheumatoid arthritis: comment on the article by Fleischmann et al and accompanying editorial by Davis.Pincus T, Block JA, Yazici Y, Bergman MJ, Sokka T.
217ClickScand J Rheumatol 2017 Sep;46(5):359-363. doi: 10.1080/03009742.2016.1234641. Epub 2016 Dec 8.Drug survival on TNF-inhibitors in patients with rheumatoid arthritis in Finland.Aaltonen,K, Joensuu, J, Pirilä, L, Kauppi, M, Uutela,T, Varjolahti-Lehtinen, T, Yli-Kerttula,T, Isomäki, P, Nordstrøm, D, Sokka, T:
Hide details for Published in 2016Published in 2016
216ClickAnn Rheum Dis. 2016 Jul;75(7):1268-71Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease.
Smolen JS, Collaud Basset S, Boers M, Breedveld F, Edwards CJ, Kvien TK, Miossec P, Sokka-Isler T, van Vollenhoven RF, Abadie EC, Bruyère O, Cooper C, Mäkinen H, Thomas T, Tugwell P, Reginster JY; European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
215ClickClin Exp Rheumatol. 2016 Sep-Oct;34(5 Suppl 101):S91-S95Go, go, GoTreatIT!Sokka T.
214ClickClin Exp Rheumatol. 2016 Jul-Aug;34(4):694-7A survey on the medication adherence to methotrexate among rheumatoid arthritis patients treated with self-administered biologic drugs.Aaltonen KJ, Turunen JH, Sokka T, Puolakka K, Valleala H.
213ClickSAGE Open Med. 2016 Jun 14;4:2050312116654404.Delivering a one-stop, integrated, patient-oriented service for patients with rheumatic diseasesVäre P, Nikiphorou E, Hannonen P, Sokka T.
212ClickBMC Musculoskelet Disord. 2016 Jun 3;17:246Long-term outcomes of destructive seronegative (rheumatoid) arthritis – description of four clinical casesNikiphorou E, Sjöwall C, Hannonen P, Rannio T, Sokka T.
211ClickJ Rheumatol. 2016 Apr;43(4):699-706.Early Remission Is a Realistic Target in a Majority of Patients with DMARD-naive Rheumatoid ArthritisRannio T, Asikainen J, Kokko A, Hannonen P, Sokka T.
210Click 2016 Jul-Aug;34(4):641-5Is long-term radiographic joint damage different between men and women? Prospective longitudinal data analysis of four early RA cohorts with greater than 15 years follow-upJ. Asikainen, E. Nikiphorou, K. Kaarela, E. Lindqvist, A. Häkkinen, P. Hannonen, T. Rannio, H. Kautiainen, T. Sokka
209ClickRheumatology (Oxford) 2016 Oct;55(10):1803-11Cost-effectiveness of biologic compared with conventional synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Register studyJoensuu JT, Aaltonen KJ, Aronen P, Sokka T, Puolakka K, Tuompo R, Korpela M, Vasala M, Ilva K, Nordström D, Blom M.
208ClickAnn Rheum Dis. 2016 Jan;75(1):3-15.Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task forceSmolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, Kvien TK, Navarro-Compán MV, Oliver S, Schoels M, Scholte-Voshaar M, Stamm T, Stoffer M, Takeuchi T, Aletaha D, Andreu JL, Aringer M, Bergman M, Betteridge N, Bijlsma H, Burkhardt H, Cardiel M, Combe B, Durez P, Fonseca JE, Gibofsky A, Gomez-Reino JJ, Graninger W, Hannonen P, Haraoui B, Kouloumas M, Landewe R, Martin-Mola E, Nash P, Ostergaard M, Östör A, Richards P, Sokka-Isler T, Thorne C, Tzioufas AG, van Vollenhoven R, de Wit M, van der Heijde D.
Hide details for Published in 2015Published in 2015
207ClickN Engl J Med. 2015 Dec 24;373(26):2534-48.Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing SpondylitisBaeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, Mpofu S, Richards HB; MEASURE 1 Study Group; MEASURE 2 Study Group
206ClickMedicina (Kaunas) 2015;51(1):25-31.Predictors of mortality in patients with rheumatoid arthritis in Lithuania: Data from a cohort study over 10 years.Dadonienė J, Stropuvienė S, Stukas R, Venalis A, Sokka-Isler T.
205ClickExpert Opin Biol Ther. 2015 15(12):1677-83Cost-Effectiveness of Biologics Compared to Conventional Disease-Modifying Antirheumatic Drugs for Treatment of Rheumatoid Arthritis in Finland.Joensuu JT, Aaltonen KJ, Aronen P, Sokka T, Puolakka K, Tuompo R, Korpela M, Vasala M, Ilva K, Nordström D, Blom M.
204ClickExpert Opin Biol Ther. 2015 Nov 7:1-7. [Epub ahead of print]Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data.Nikiphorou E, Kautiainen H, Hannonen P, Asikainen J, Kokko A, Rannio T, Sokka T.
203ClickJ Rheumatol. 2015 Sep;42(9):1542-4.Rheumatoid Arthritis in the 21st Century: Treatment Patterns and Disease Activity States.Nikiphorou E, Rannio T, Sokka T.
202ClickArthritis Res Ther. 2015 Aug 20;17(1):219Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern NorwayHaugeberg G, Hansen IJ, Soldal DM, Sokka T.
Left Arrow IconPreviousRight Arrow IconNextPlus IconExpandMinus IconCollapseMagnifying Glass IconSearch